About: Prognostic factors for severity and mortality in patients infected with COVID-19: A living systematic review protocol

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prognostic factors for severity and mortality in patients infected with COVID-19: A living systematic review protocol Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Prognostic factors for severity and mortality in patients infected with COVID-19: A living systematic review protocol
Creator	Epistemonikos, Fundación Rada, Gabriel Santiago, Agnoletti, Camila Agust Í N Bengolea, Andrea, María Catalano, Hugo Ceirano, Agustina Espinosa, Federico Izcovich, Ariel Marzio, Lavena Ragusa, Martín Saavedra, Ezequiel Tortosa, Fernando
Source	MedRxiv
abstract	Objective The objective of our systematic review is to identify prognostic factors that can potentially be used in decision-making related to the care of patients infected with COVID-19. Design This is the protocol of a living systematic review. Data sources We will conduct searches in PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), grey literature and in a centralised repository in L-OVE (Living OVerview of Evidence). L-OVE is a platform that maps PICO questions to evidence from Epistemonikos database. In response to the COVID-19 emergency, L-OVE was adapted to expand the range of evidence it covers and customised to group all COVID-19 evidence in one place. The search will cover the period until the day before submission to a journal. Eligibility criteria for selecting studies and methods We will follow a common protocol for multiple parallel systematic reviews, already published and submitted to PROSPERO (awaiting ID allocation). We will include studies that assess patients with confirmed or suspected infection with SARS-CoV-2 and inform the relation of potential prognostic factors with death or disease severity. Two groups of two reviewers will independently screen studies for eligibility, extract data, and assess the risk of bias. We will perform meta-analyses and use GRADE to assess the certainty of evidence for each prognostic factor and outcome. A living, web-based version of this review will be openly available during the COVID-19 pandemic. We will resubmit it if the conclusions change or there are substantial updates. Ethics and dissemination No ethics approval is considered necessary. The results of this review will be widely disseminated via peer-reviewed publications, social networks and traditional media.
has issue date	2020-04-11(xsd:dateTime)
bibo:doi	10.1101/2020.04.08.20056598
has license	medrxiv
sha1sum (hex)	cf4cad81492fa69b8fdc6ec5f8a67eebf37d79ef
schema:url	https://doi.org/10.1101/2020.04.08.20056598
resource representing a document's title	Prognostic factors for severity and mortality in patients infected with COVID-19: A living systematic review protocol
resource representing a document's body	covid:cf4cad81492fa69b8fdc6ec5f8a67eebf37d79ef#body_text
is schema:about of	named entity 'patients' named entity 'factors' named entity 'doi' named entity 'protocol' named entity 'OBJECTIVE' named entity 'DECISION-MAKING' named entity 'odds ratio' named entity 'middle east respiratory syndrome' named entity 'infection' named entity 'odds ratio' named entity 'odds ratio' named entity 'odds ratio' named entity 'PROSPERO' named entity 'prognostic factor' named entity 'prognostic factor' named entity 'odds ratio' named entity 'prognostic factor' named entity 'Prognostic' named entity 'COVID' named entity 'risk assessment' named entity 'copyright holder' named entity 'odds ratio' named entity 'odds ratio' named entity 'odds ratio' named entity 'infection' named entity 'copyright holder' named entity 'preprint' named entity '2019-nCoV' named entity 'COVID-19' named entity 'infection' named entity 'sars-cov-2' named entity 'doi' named entity 'peer-reviewed' named entity 'copyright holder' named entity 'viruses' named entity 'Sensitivity analysis' named entity 'care' named entity 'COVID-19' named entity 'systematic review' named entity 'Prognostic' named entity 'systematic review' named entity 'preprint' named entity 'doi' named entity 'copyright holder' named entity 'preprint' named entity 'PROSPERO' named entity 'odds ratio' named entity 'database' named entity 'confidence intervals' named entity 'database' named entity 'medRxiv' named entity 'preprint' named entity 'MERS-CoV' named entity 'COVID' named entity 'preprint' named entity 'infection' named entity 'CC-BY-NC-ND 4.0' named entity 'odds ratio' named entity 'preprint' named entity 'preprint' named entity 'odds ratio' named entity 'MEDLINE' named entity 'COVID-19 outbreak' named entity 'odds ratio' named entity 'preprint' named entity 'Coronavirus' named entity 'medRxiv' named entity 'prognostic factor' named entity 'sensitivity analysis' named entity 'pneumonia' named entity 'metafor' named entity 'virus'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software